Publication Date:
1980-08-15
Description:
Selenium, administered to mice with Ehrlich ascites tumors, effectively limited tumor growth. The response was dependent on the chemical form and dose of selenium administered. At the doses administered, there were no detectable adverse effects to the host.〈br /〉〈span class="detail_caption"〉Notes: 〈/span〉Greeder, G A -- Milner, J A -- New York, N.Y. -- Science. 1980 Aug 15;209(4458):825-7.〈br /〉〈span class="detail_caption"〉Record origin:〈/span〉 〈a href="http://www.ncbi.nlm.nih.gov/pubmed/7406957" target="_blank"〉PubMed〈/a〉
Keywords:
Animals
;
Carcinoma, Ehrlich Tumor/*drug therapy/pathology
;
Cell Line
;
Cell Membrane Permeability
;
Cystine/analogs & derivatives
;
Dose-Response Relationship, Drug
;
Male
;
Mice
;
Neoplasm Transplantation
;
Selenium/*administration & dosage/metabolism/therapeutic use
;
Selenomethionine/administration & dosage
Print ISSN:
0036-8075
Electronic ISSN:
1095-9203
Topics:
Biology
,
Chemistry and Pharmacology
,
Computer Science
,
Medicine
,
Natural Sciences in General
,
Physics
